Publications & Development

2024:

Prediction of Alzheimer’s disease progression within 6 years using speech: A novel approach leveraging language models (Alzheimer’s & Dementia Journal)

Speech patterns during memory recall relates to early tau burden across adulthood (Alzheimer’s & Dementia Journal) 

Sex‐specific blood biomarkers linked to memory changes in middle‐aged adults: The Framingham Heart Study (Alzheimer’s & Dementia Journal)

Digital neuropsychological measures by defense automated neurocognitive assessment: reference values and clinical correlates (Frontiers in Neurology)

Shifting from Active to Passive Monitoring of Alzheimer’s Disease: The State of the Research (Journal of the American Heart Association)

Comparing Cognitive Tests and Smartphone‐Based Assessment in 2 US Community‐Based Cohorts (Journal of the American Heart Association)

Design and Feasibility Analysis of a Smartphone‐Based Digital Cognitive Assessment Study in the Framingham Heart Study (Journal of the American Heart Association)

Challenge of Optimizing Medical Therapy in Heart Failure: Unlocking the Potential of Digital Health and Patient Engagement (Journal of the American Heart Association)

American Heart Association Focusing Research Rigor on Digital Health (Journal of the American Heart Association)

Digital Clock Drawing as an Alzheimer’s Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults (The Journal of Prevention of Alzheimer’s Disease)

2023:

Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer’s disease and related dementia research (Alzheimer’s & Dementia Journal)

Association between acoustic features and brain volumes: the Framingham Heart Study (Frontiers in Dementia)

Disease-driven domain generalization for neuroimaging-based assessment of Alzheimer’s disease (medRxiv)

BMI decline patterns and relation to dementia risk across four decades of follow-up in the Framingham Study (Alzheimer’s & Dementia Journal)

Matching science to reality: how to deploy a participant-driven digital brain health platform (Frontiers in Dementia)

2022:

Multimodal deep learning for Alzheimer’s disease dementia assessment (Nature Communications)

Feasibility of frequent self-administered mobile cognitive assessments in adults with and without cognitive impairment – Abstract (Alzheimer’s & Dementia)

Multimodal, longitudinal digital brain health platform using participant-driven study design – Abstract (Alzheimer’s & Dementia)

Evaluation of COVID on cognitive performance using a mobile application – Abstract (Alzheimer’s & Dementia)

Davos Alzheimer’s Collaborative: Building a globally representative cohort through a technologically-enabled approach – Abstract (Alzheimer’s & Dementia)